Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis


Aging is characterized by clonal expansion of myeloid-biased hematopoietic stem cells and by increased risk of myeloid malignancies. Exome sequencing of three elderly females with clonal hematopoiesis, demonstrated by X-inactivation analysis, identified somatic TET2 mutations. Recurrence testing identified TET2 mutations in 10 out of 182 individuals with X-inactivation skewing. TET2 mutations were specific to individuals with clonal hematopoiesis without hematological malignancies and were associated with alterations in DNA methylation.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type



Prices may be subject to local taxes which are calculated during checkout

Figure 1: Somatic TET2 mutations are present in normal elderly individuals with myeloid skewing and are associated with epigenetic alterations.

Accession codes


NCBI Reference Sequence


  1. Beerman, I., Maloney, W.J., Weissmann, I.L. & Rossi, D.J. Curr. Opin. Immunol. 22, 500–506 (2010).

    Article  CAS  Google Scholar 

  2. Beerman, I. et al. Proc. Natl. Acad. Sci. USA 107, 5465–5470 (2010).

    Article  CAS  Google Scholar 

  3. Busque, L. et al. Blood 88, 59 (1996).

    CAS  PubMed  Google Scholar 

  4. Gale, R.E., Fielding, A.K., Harrison, C.N. & Linch, D.C. Br. J. Haematol. 98, 512–519 (1997).

    Article  CAS  Google Scholar 

  5. Busque, L. & Gilliland, D.G. Leukemia 12, 128–135 (1998).

    Article  CAS  Google Scholar 

  6. Delhommeau, F. et al. N. Engl. J. Med. 360, 2289–2301 (2009).

    Article  Google Scholar 

  7. Moran-Crusio, K. et al. Cancer Cell 20, 11–24 (2011).

    Article  CAS  Google Scholar 

  8. Quivoron, C. et al. Cancer Cell 20, 25–38 (2011).

    Article  CAS  Google Scholar 

  9. Li, Z. et al. Blood 118, 4509–4518 (2011).

    Article  CAS  Google Scholar 

  10. Ko, M. et al. Proc. Natl. Acad. Sci. USA 108, 14566–14571 (2011).

    Article  CAS  Google Scholar 

  11. Tefferi, A. et al. Leukemia 23, 905–911 (2009).

    Article  CAS  Google Scholar 

  12. Ko, M. et al. Nature 468, 839–843 (2010).

    Article  CAS  Google Scholar 

  13. Figueroa, M.E. et al. Cancer Cell 18, 553–567 (2010).

    Article  CAS  Google Scholar 

Download references


We thank members of the Levine and Busque laboratories for helpful comments and discussion. This work was supported by a grant from the National Cancer Institute Physical Sciences Oncology Center (U54CA143798-01) to R.L.L. and A.M., by grant 1R01CA138234-01 to R.L.L. and by grants 1R01CA129831 and 1R01CA129831-03S1 to L.A.G. from the National Cancer Institute. A. Vasanthakumar is supported by a US National Institutes of Health F32 award. M.E.F. is supported by a Leukemia and Lymphoma Society Special Fellow award and a Doris Duke Charitable Foundation Clinical Scientist Development Award. O.A.-W. is an American Society of Hematology Basic Research Fellow. A.M. is a Burroughs Wellcome Clinical Translational Scholar and is also supported by the Sackler Center for Biomedical and Physical Sciences. R.L.L. is an Early Career Award Recipient of the Howard Hughes Medical Institute. R.L.L. and A.M. are funded by Leukemia and Lymphoma Society Scholar Awards. All subjects answered a medical questionnaire and gave informed consent. The study was approved by the Maisonneuve-Rosemont Hospital's Ethics Committee in 1998 and is reapproved yearly in accordance with institutional bylaws.

Author information

Authors and Affiliations



L.B., J.P.P., O.A.-W. and R.L.L. designed the study. L.B., S.P., Z.H. and L.M. collected samples and provided genetic and clinical annotation. J.P.P., J.L., A. Vasanthakumar, A.H., M.H., N.S., P.K.B., C.E.M. and C.W.B. performed sequence analysis and validated mutations. M.E.F., A. Viale, A.M. and L.A.G. performed methylation analysis. M.G. performed statistical analysis. L.B., J.P.P., O.A.-W. and R.L.L. wrote the manuscript.

Corresponding authors

Correspondence to Lambert Busque or Ross L Levine.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Text and Figures

Supplementary Methods, Supplementary Figures 1 and 2 and Supplementary Tables 1–4 (PDF 1427 kb)

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Busque, L., Patel, J., Figueroa, M. et al. Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis. Nat Genet 44, 1179–1181 (2012).

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI:

This article is cited by


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing